HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Leaves Divesting Out Of Value-Building Tool Box – CFO

This article was originally published in The Tan Sheet

Executive Summary

P&G CFO Jon Moeller says splitting up or spinning off business units is a relevant question, but is a short-term approach while the firm is focused on long-term value building through innovation. During an investor conference, he also discusses plans to boost promotional spending.

You may also be interested in...



Change At P&G Helm But Not In Course

Speaking at conferences or in P&G’s earnings briefings wasn’t part of previous CEO David Taylor’s strategy. But Jon Moeller has been a mainstay of P&G presentations for years and likely will continue the role.

Batteries Not Included: P&G Plans Duracell Divestiture

The firm’s plan to splin off or otherwise divest Duracell raises the question of whether billion dollar brands could follow. Separately, the firm confirms that Melanie Healey, North America head of operations – previously seen as a potential candidate to succeed current CEO A.G. Lafley – will retire in June 2015.

Lafley Back At P&G Helm As McDonald’s Tenure Ends At Four Years

Procter & Gamble turns to its former leader, previously replaced by Bob McDonald in 2009, after facing investor and analyst pressure to shake up management. Lafley’s return as CEO “provides us with new hope,” one market analyst says.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123589

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel